News | March 03, 2024
Briefs: SMS Pharmaceuticals and Vimta Labs
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
BHL will undertake the development and supply of these molecules
_in_Mizushima,_Japan_256_384.jpg)
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
VeerHealth Care will be raising Rs. 8 crores through bank borrowings
The board gave in-principle approval for expansion of company's footprint in Lucknow
Subscribe To Our Newsletter & Stay Updated
